Our progress
In 2 years Evithé Biotechnology has taken the product through pre-clinical research and phase 1 clinical trials at a fraction of the cost of a pharmaceutical drug.
Using reverse pharmacology, we move faster, safer, and at a lower cost
Below you can get an overview of our progress and Milestones since the founding of Evithé Biotechnology in November 2021.
2025
- Series(?) Funding
- Phase 1 Clinical trial completed
- Clinical trial results?
2024
- Provisional Patent 3 filed
- Phase 1 Clinical Trial started
- Characterisation protocol finalised
- Batch to Batch consistency achieved
- Sustainable agricultural development expanded across Asia Pacific
- Built relationships towards out-licensing
- GMP Manufacturing
2023
- (Series A?) Funding secured
- Provisional Patent 2 filed
- Patent 1 published
- Clinical Pilot studies started
- Clinical Trial batches produced
- Lead 3 optimisation
- Lead 3 in vivo
- Pharmacokinetic studies
- Investigational new drug applications
- Certificate of Analysis
- Expand Team
- Advance Botanical Drug manufacturing at scale
2022
- (Seed?) funding secured
- Defence Compounds Discovered
- 3 Product Leads Identified
- Proof of Concept
- Botanical Drug Lead Optimisation
- Scaled manufacturing from Lab to 500kg
- Established Safety Profiles
- Pre-Clinical Development
- Completed FDA Pre-investigational new drug application botanical drugs with FDA
- Established Fiji Raw Materials pathway
- Good agricultural practice farmers (GLOBAL GAP)
- Clinical Protocols
- Team expansion
2021
- Evithé Biotechnology is founded in November 2021 by Cynthia Hunefeld